Please enable Javascript
Michael Dickinson, MBBS, DMedSc, FRACP, FRACPA
Articles by Michael Dickinson, MBBS, DMedSc, FRACP, FRACPA
Michael Dickinson, MBBS, DMedSc, on Glofitamab Combination Trials Underway
Michael Dickinson, MBBS, DMedSc, FRACP, FRACPA
Multimedia
|
January 20, 2023
Michael Dickinson, MBBS, DMedSc, discusses trials in progress that are evaluating glofitamab with other agents for DLBCL.
View More
Michael Dickinson, MBBS, DMedSc, on a Phase II Trial of Glofitamab in DLBCL
Michael Dickinson, MBBS, DMedSc, FRACP, FRACPA
Multimedia
|
January 18, 2023
Michael Dickinson, MBBS, DMedSc, discusses a phase II trial of glofitamab, a bispecific antibody, in patients with DLBCL.
View More
Michael Dickinson, MBBS, DMedSc, on ASH Glofitamab Updates
Michael Dickinson, MBBS, DMedSc, FRACP, FRACPA
Multimedia
|
January 13, 2023
Michael Dickinson, MBBS, DMedSc, discusses updates on glofitamab that were presented during the 2022 ASH meeting.
View More